Detailed information of RBPJ

  1. Home
  2. TF > RBPJ

Dataset summary

TF Name: RBPJ Species: Homo sapiens
Cell-type/Tissue: HUVEC-C (HUVEC, umbilical vein endothelial cells) Condition/Source: Treatment: agent VEGF, timepoint 12 Passage: P3-6
JASPAR ID: MA1116.1 Collections: Permissive
References: GEO GSE109625 GSM2947456 GTRD EXP048216

External links

Models for profile: MA1116.1

Download TFBSs (hg38)

Download TFBSs in BED and FASTA format

Download trained model

Download trained prediction models

Visualize TFBSs in UCSC

Send TFBSs BED file to UCSC genome browser

Summary plots

Statistical details

Model Peak caller Model ID Enrichment Zone TFBSs Score threshold Centrality p-value (log10)
DAMO MACS MA1116.1 55.5 3672 86.7 -1.03814340317842

40 datasets found for the same TF (RBPJ) in other cell-types/tissues

TF Name Cell-line Condition/Source Collections Species Identifiers JASPAR ID
RBPJ CUTLL1 (T-cell lymphoblastic lymphoma 1) GSI 72 hrs Permissive Homo sapiens GSE51800 ... MA1116.1
RBPJ CUTLL1 (T-cell lymphoblastic lymphoma 1) GSI 72 hrs, wash out 4 hrs Permissive Robust Homo sapiens GSE51800 ... MA1116.1
RBPJ HUVEC-C (HUVEC, umbilical vein endothelial cells) Treatment: agent VEGF, timepoint 0 Passage: P3-6 Permissive Homo sapiens GSE109625 ... MA1116.1
RBPJ HUVEC-C (HUVEC, umbilical vein endothelial cells) Treatment: agent VEGF, timepoint 1 Passage: P3-6 Permissive Homo sapiens GSE109625 ... MA1116.1
RBPJ HUVEC-C (HUVEC, umbilical vein endothelial cells) Treatment: agent VEGF, timepoint 4 Passage: P3-6 Permissive Homo sapiens GSE109625 ... MA1116.1
RBPJ HUVEC-C (HUVEC, umbilical vein endothelial cells) Treatment: Superconfluent, untreated Passage: 4 Permissive Homo sapiens GSE87552 ... MA1116.1
RBPJ REC-1 (Mantle cell lymphoma) Treatment: untreated Permissive Robust Homo sapiens GSE97541 ... MA1116.1
RBPJ SP-49 (Mantle cell lymphoma) Treatment: untreated Permissive Robust Homo sapiens GSE97541 ... MA1116.1
RBPJ REC-1 (Mantle cell lymphoma) Treatment: GSI-mock-washout Permissive Homo sapiens GSE97541 ... MA1116.1
RBPJ REC-1 (Mantle cell lymphoma) Treatment: GSI-washout Permissive Homo sapiens GSE97541 ... MA1116.1
RBPJ LAL-B (All-B patient-derived cell line) Treatment: chronic 1 uM dasatinib; Permissive Homo sapiens GSE74557 ... MA1116.1
RBPJ LAL-B (All-B patient-derived cell line) Treatment: 12 day 1 uM dasatinib; Permissive Homo sapiens GSE74557 ... MA1116.1
RBPJ LAL-B (All-B patient-derived cell line) Treatment: none; Permissive Robust Homo sapiens GSE74557 ... MA1116.1
RBPJ C2C12 (myoblasts) Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs; Permissive Mus musculus GSE37184 ... MA1116.1
RBPJ C2C12 (myoblasts) DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs Permissive Mus musculus GSE37184 ... MA1116.1
RBPJ C2C12 (myoblasts) Treatment: doxycycline; Genotype: NICDGFP; Permissive Robust Mus musculus GSE37184 ... MA1116.1
RBPJ C2C12 (myoblasts) DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs Permissive Mus musculus GSE37184 ... MA1116.1
RBPJ C2C12 (myoblasts) Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 24 hrs; Permissive Mus musculus GSE37184 ... MA1116.1
RBPJ C2C12 (myoblasts) DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 24hrs Permissive Mus musculus GSE37184 ... MA1116.1
RBPJ F9 (embryonal carcinoma) Developmental stage: cycling cells (containing 95% interphase and 5% mitosis cells); Permissive Mus musculus GSE45889 ... MA1116.1
RBPJ F9 (embryonal carcinoma) Developmental stage: mitotic cells; Permissive Mus musculus GSE45889 ... MA1116.1
RBPJ primary murine T-ALL (acute lymphocytic leukemia) cells Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; Permissive Robust Mus musculus GSE61504 ... MA1116.1
RBPJ primary murine T-ALL (acute lymphocytic leukemia) cells Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; Permissive Robust Mus musculus GSE61504 ... MA1116.1
RBPJ MDA-MB-157 (triple negative breast carcinoma) Treatment: GSI-washout; Permissive Homo sapiens GSE116868 ... MA1116.1
RBPJ MDA-MB-157 (triple negative breast carcinoma) Treatment: GSI-mock-washout; Permissive Homo sapiens GSE116868 ... MA1116.1
RBPJ HCC-1599(ductal breast carcinoma) Treatment: GSI-washout; Permissive Homo sapiens GSE116871 ... MA1116.1
RBPJ HCC-1599(ductal breast carcinoma) Treatment: GSI-mock-washouts; Permissive Homo sapiens GSE116871 ... MA1116.1
RBPJ brain pericytes Treatment: None; Strain: RD1; Permissive Robust Mus musculus GSE120482 ... MA1116.1
RBPJ brain pericytes Treatment: None; Strain: RD1; Permissive Robust Mus musculus GSE120482 ... MA1116.1
RBPJ HepG2 (hepatoblastoma) Permissive Homo sapiens ENCSR596FEL MA1116.1
RBPJ neural tube Permissive Mus musculus GSE47459 ... MA1116.1
RBPJ T29 (T-cell leukemia) Permissive Mus musculus GSE46119 ... MA1116.1
RBPJ T29 (T-cell leukemia) Permissive Robust Mus musculus GSE46119 ... MA1116.1
RBPJ 8946 cells - Flag-Zmiz1/ L1601PDP (T lymphoblastic leukemia) Permissive Mus musculus GSE66146 ... MA1116.1
RBPJ MDA-MB-231 (breast adenocarcinoma) Permissive Homo sapiens GSE100375 ... MA1116.1
RBPJ Permissive Robust Homo sapiens GSE29498 MA1116.1
RBPJ CUTLL1 (T-cell lymphoblastic lymphoma 1) Permissive Robust Homo sapiens GSE29600 MA1116.1
RBPJ LCL (lymphoblastoid cell line) Permissive Homo sapiens GSE75503 MA1116.1
RBPJ Permissive Homo sapiens GSE75503 MA1116.1
RBPJ Permissive Homo sapiens GSE79734 MA1116.1